Rifampicin-resistant Tuberculosis: A Global Health Dilemma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rifampicin-resistant Tuberculosis: A Global Health Dilemma

Published:2024-02-20 Issue:2 Volume:14 Page:87-91
ISSN:2321-8568
Container-title:Advances in Human Biology
language:en
Short-container-title:

Author:

Ahmad Rahnuma¹,Sinha Susmita²,Chowdhury Kona³,Haque Mainul⁴⁵

Affiliation:

1. Department of Physiology, Medical College for Women and Hospital, Dhaka, Bangladesh

2. Department of Physiology, Khulna City Medical College and Hospital, Khulna, Bangladesh

3. Department of Paediatrics, Gonoshasthaya Samaj Vittik Medical College and Hospital, Dhaka, Bangladesh

4. Unit of Pharmacology, Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kuala Lumpur, Malaysia

5. Department of Research, Karnavati Scientific Research Center, Karnavati School of Dentistry, Karnavati University, Gandhinagar, Gujarat, India

Publisher

Medknow

Reference64 articles.

1. High proportion of RR-TB and mutations conferring RR outside of the RRDR of the rpoB gene detected in GeneXpert MTB/RIF assay positive pulmonary tuberculosis cases, in Addis Ababa, Ethiopia;Akalu;PLoS One,2022

2. The social drivers of tuberculosis, reconfirmed;Trajman;Lancet Infect Dis,2024

3. Rifampicin-resistant tuberculosis in Iran: A systematic review and meta-analysis;Bahraminia;Iran J Basic Med Sci,2021

4. Global Tuberculosis Report 2023. License: CC BY-NC-SA 3.0 IGO. Geneva: World Health Organization,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP